Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults.
The Lycopene Food Colors Market is driven by rising demand for natural food colorants in the food and beverage industry. Ankush Nikam Future Market Insights, Inc. + +91 90966 84197 email us here Visit ...
Whether you’re looking to replace Red 3 & 40, Blue 1 & 2, Yellow 5 & 6 or Green 3, here’s a list of replacements from suppliers.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Is there a difference between 'antibiotic-free' eggs and 'no antibiotics ever' eggs? What about 'vegetarian-fed' versus 'organic?' Here's what egg carton labels really mean.
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
Robert F. Kennedy Jr.'s long record of doubting the safety of childhood vaccinations persisted as a flash point for him ...
Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on strong efficacy shown in previous studies, the drugmaker said on Thursday.